ARCHIVES

Survey Finds 70 Percent of Oncologists Prescribe Avastin Off-Label For Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Panel urges Breast Implant Studies, Says Devices Should Remain Available

November 22, 1991

Not All Women Benefitting From Less Invasive Staging

April 25, 2008

In Congress: Societies, Advocates, Testify For Increases In Research Funding

February 13, 1998

Obey Says NCI “Must Do Better,” Response Dispute GAO Conclusion

August 8, 1980

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

April 26, 2013

In Brief: USC Study Finds Sedentary Occupations Increase Colon Cancer Risk for Men Over More Active Jobs

November 30, 1984